Developing, Validating, and Testing Non-vaccine–Preventable Human Papillomavirus to Control for Differences in Sexual Behavior When Evaluating HPV Vaccination
NVP-HPV might be used to control for changes in HPV transmission risk over time and between groups when evaluating vaccination impact/effectiveness.
Authors
- Kate Soldan (ORCID: https://orcid.org/0000-0002-0361-3174)
- Marta Checchi (ORCID: https://orcid.org/0000-0003-1398-9017)
- Pam Sonnenberg (ORCID: https://orcid.org/0000-0002-1067-1583)
- Danping Liu (ORCID: https://orcid.org/0000-0001-5483-6303)
- Aimée R. Kreimer (ORCID: https://orcid.org/0000-0002-6073-2591)
- Simon Beddows (ORCID: https://orcid.org/0000-0002-6879-6215)
- Emily Dema (ORCID: https://orcid.org/0000-0002-7254-2023)
- Mónica S. Sierra
- Cameron B. Haas (ORCID: https://orcid.org/0000-0002-8211-0806)
- Nigel Field (ORCID: https://orcid.org/0000-0002-2825-6652)
- Jaimie Z. Shing (ORCID: https://orcid.org/0000-0001-7064-4424)
Institutions
- National Institutes of Health (US)
- The George Institute for Global Health (GB)
- Public Health England (GB)
- National Cancer Institute (US)
- UK Health Security Agency (GB)
- Division of Cancer Epidemiology and Genetics
- University College London (GB)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1775
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00